G1 Therapeutics, Inc. - COM (GTHX)

Historical Portfolio Holders from Q2 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
14 M
Holdings value Q1 2024
$60.3 M
Value change Q1 2024
+$8.66 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
80
Number of buys Q1 2024
47
Number of sells Q1 2024
-33
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
3621LQ109
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 14 M $60.3 M +$8.66 M $4.32 80
2023 Q4 12.4 M $38 M +$4.8 M $3.05 83
2023 Q3 10.9 M $15.8 M -$9.17 M $1.44 70
2023 Q2 15.4 M $38.5 M -$9.36 M $2.49 77
2023 Q1 19.1 M $51.3 M -$16.5 M $2.68 94
2022 Q4 22.8 M $124 M -$17.8 M $5.43 111
2022 Q3 23 M $286 M +$45 M $12.49 97
2022 Q2 19.6 M $96.9 M -$25.8 M $4.94 84
2022 Q1 23.4 M $178 M -$17.5 M $7.60 103
2021 Q4 26.3 M $269 M -$2.02 M $10.21 98
2021 Q3 22.6 M $304 M +$24.2 M $13.42 107
2021 Q2 24.6 M $539 M +$8.87 M $21.94 109
2021 Q1 24.2 M $581 M +$14.3 M $24.06 119
2020 Q4 24.1 M $433 M -$92.1 M $17.99 118
2020 Q3 29.3 M $339 M -$4.76 M $11.55 112
2020 Q2 24.9 M $604 M -$6.19 M $24.26 94
2020 Q1 26.2 M $289 M -$31.2 M $11.02 92
2019 Q4 29.9 M $791 M -$11.8 M $26.43 95
2019 Q3 28.4 M $646 M +$9.04 M $22.78 91
2019 Q2 28.1 M $863 M +$44.3 M $30.66 93
2019 Q1 27.1 M $450 M -$7.13 M $16.60 87
2018 Q4 27.4 M $525 M -$92.9 M $19.15 90
2018 Q3 26.4 M $1.37 B +$177 M $52.29 113
2018 Q2 23 M $998 M +$140 M $43.46 92
2018 Q1 20 M $741 M +$238 M $37.05 94
2017 Q4 13.6 M $270 M +$24 M $19.84 57
2017 Q3 9.65 M $239 M +$59.7 M $24.89 41
2017 Q2 9.97 M $174 M +$174 M $17.44 27